Cargando…
Investigating a Library of Flavonoids as Potential Inhibitors of a Cancer Therapeutic Target MEK2 Using in Silico Methods
The second leading cause of death in the world is cancer. Mitogen-activated protein kinase (MAPK) and extracellular signal-regulated protein kinase (ERK) 1 and 2 (MEK1/2) stand out among the different anticancer therapeutic targets. Many MEK1/2 inhibitors are approved and widely used as anticancer d...
Autores principales: | AlZahrani, Wejdan M., AlGhamdi, Shareefa A., Sohrab, Sayed S., Rehan, Mohd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002492/ https://www.ncbi.nlm.nih.gov/pubmed/36901876 http://dx.doi.org/10.3390/ijms24054446 |
Ejemplares similares
-
Exploring the Natural Compounds in Flavonoids for Their Potential Inhibition of Cancer Therapeutic Target MEK1 Using Computational Methods
por: AlZahrani, Wejdan M., et al.
Publicado: (2022) -
Analysis of some flavonoids for inhibitory mechanism against cancer target phosphatidylinositol 3-kinase (PI3K) using computational tool
por: Suhail, Mohd, et al.
Publicado: (2023) -
In Silico Investigation of Flavonoids as Potential Trypanosomal Nucleoside Hydrolase Inhibitors
por: Ha, Christina Hung Hung, et al.
Publicado: (2015) -
Investigation renin inhibitor activity from flavonoids derivates by in silico study
por: Eff, Aprilita Rina Yanti, et al.
Publicado: (2023) -
Inhibition of human amylin aggregation by Flavonoid Chrysin: An in-silico and in-vitro approach
por: Alkahtane, Abdullah A., et al.
Publicado: (2021)